Tubal patency after clinical treatment of unruptured ectopic pregnancy.
Int J Gynaecol Obstet
; 88(3): 309-13, 2005 Mar.
Article
en En
| MEDLINE
| ID: mdl-15733887
OBJECTIVE: To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. METHOD: Of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. RESULTS: Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. In addition, contralateral tubal patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. CONCLUSION: Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Embarazo Tubario
/
Trompas Uterinas
Tipo de estudio:
Observational_studies
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Int J Gynaecol Obstet
Año:
2005
Tipo del documento:
Article
País de afiliación:
Brasil
Pais de publicación:
Estados Unidos